Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Alcohol Clin Exp Res. 2020 Jul 3;44(8):1625–1635. doi: 10.1111/acer.14386

Table 3.

Cardiovascular disease (CVD) at Wave 2 among those with Wave 1 CVD (Persistence) by Wave 1 WHO risk drinking level and change in WHO risk level between Waves 1 and 2.

Wave 1 WHO risk level
and change by Wave 2
Wave 1 very-high-risk and high-risk drinkers with Wave 1
CVD (n=241)
n Adjusted
Prevalence of
Wave 2 CVD
Adjusted OR
(95% CI)
p-value
Wave 1 Very high risk
Not decreased by ≧2 levels 60 62.9% Reference
Decreased by ≧2 levels 61 65.5% 1.12 (0.60-2.08) 0.7275
Wave 1 High risk
Not decreased by ≧2 levels 70 67.5% Reference
Decreased by ≧2 levels 50 59.4% 0.71 (0.51–0.97) 0.0314
a

Prevalence values are calculated from the same logistic regression used to obtain adjusted OR values which controls for Wave 1 covariates (sex, age, education, race and ethnicity, smoking, body-mass index, health insurance, presence of psychiatric condition).